T he differentiation pathway from stem cell to mature B lymphocyte can be divided into several stages, characterized by differentiation processes, proliferation phases, and control steps. Precursor B cells differentiate into immature B lymphocytes after successfully expressing a surface Ig receptor (IgM). These immature B cells emerge from the bone marrow (BM) 3 to the periphery and migrate into the spleen for their final maturation step. This migration proceeds through the terminal branches of central arterioles to blood sinusoids of the marginal zone (1, 2). Before arriving at the spleen, the optimal site of their maturation, immature B cells are excluded from nonsplenic secondary lymphoid organs and from sites of infection and inflammation, where Ag encounter could lead to effective clonal elimination because of the negative selection process.
T he differentiation pathway from stem cell to mature B lymphocyte can be divided into several stages, characterized by differentiation processes, proliferation phases, and control steps. Precursor B cells differentiate into immature B lymphocytes after successfully expressing a surface Ig receptor (IgM). These immature B cells emerge from the bone marrow (BM) 3 to the periphery and migrate into the spleen for their final maturation step. This migration proceeds through the terminal branches of central arterioles to blood sinusoids of the marginal zone (1, 2) . Before arriving at the spleen, the optimal site of their maturation, immature B cells are excluded from nonsplenic secondary lymphoid organs and from sites of infection and inflammation, where Ag encounter could lead to effective clonal elimination because of the negative selection process.
Previously we demonstrated that immature B cells can downregulate their own integrin-mediated adhesion to the extracellular matrix and thereby suppress their migration into nonsplenic sites (3) . This inhibition is mediated by IFN-␥, which is transcribed and secreted at low levels by immature B cells. The inhibitory signal of IFN-␥ is transmitted through the IFN-␥R, whose engagement leads to inhibition of cytoskeleton rearrangement, which is required for promoting integrin-mediated adhesion and migration of B cells (4, 5) . We have shown that IFN-␥ secretion is regulated by the MHC class I receptor, Ly49D. This activating receptor is expressed on peripheral immature B cells and recognizes MHC class I on peripheral tissues. Ly49D and MHC class I interaction induces stable secretion of IFN-␥ by immature B cells, thereby down-regulating their homing to the lymph nodes (LN) or to sites of inflammation (6) .
It was previously shown that effector cells that express the activating Ly49D receptor also coexpress, at very high levels, the inhibitory Ly49G2 or Ly49A receptors, which recognize the same MHC class I ligand and dominate over the activating function (7). Co-cross-linking with anti-Ly49G2 and anti-Ly49D blocks Ly49D mediated activation and IFN-␥ secretion (8) . Thus, engagement of activating Ly49 NK receptors in vivo appears to be constantly balanced by inhibitory forces. The biological role of such tight regulation remains unknown.
To test whether this mechanism exists in B cells, we analyzed Ly49G2 transcription and translation in immature and mature B cell populations. We show in this study that low levels of Ly49G2 are expressed on peripheral immature B cells, whereas BM immature and peripheral mature B cells elevate its levels. We suggest that the outcome of the stimulation of both inhibitory and activating Ly49 receptors depends on their cell surface levels. Low levels of Ly49D expressed on immature BM and on mature B cells can induce IFN-␥ transcription; however, this process is inhibited by the dominant inhibitory effect mediated by the Ly49G2 receptor. In peripheral immature B cells, Ly49G2 levels are low, allowing transcription of low levels of IFN-␥.
Materials and Methods

Mice Cells and separation of B cells
Spleen and BM cells were obtained from the various mice as previously described (11, 12) . The purity of the purified cells (between 95 and 98%) was analyzed by FACS after each experiment. Ii Ϫ/Ϫ B cells were purified using CD19 beads. Control IgD Ϫ cells were separated from IgD ϩ B cells using the MACS system. To separate the IgD Ϫ and CD21-positive and -negative populations, IgD Ϫ cells were separated according to their CD21 expression using the MACS system as previously described (6, 12) . To isolate T1, T2, and mature B cells, we followed the procedures described previously (13) . Briefly, the non-B cell population was depleted using a B cell-negative selection kit (Miltenyi Biotec). The purified B cells were then sorted into various populations using anti-CD21, anti-CD24, and anti-CD23 mAb: T1 cells: CD21 
RNA isolation and RT
Total RNA was isolated from cells using the Tri-Reagent kit (Molecular Research Center). RT was conducted using SuperScript II RT (Invitrogen Life Technologies). The primers used included: Ly49D, 5Ј-CCTGGCAGCTCAT TGTGATAG-3Ј and 5ЈATTCTGGCAGCTCTGTTTACATC-3Ј; IFN-␥, 5Ј-CATTGAAAGCCTAGAAAGTCTG-3Ј and 5Ј-CTCATGAATGCATCCTT TTTCG-3Ј; hypoxanthine phosphoribosyltransferase, 5Ј-GAGGGTAGGCT GGCCTATGGCT-3Ј and 5GTTGGATACAGGCCAGACTTTGTTG-3Ј; and Ly49G2, 5Ј-GGCAATGATCTTCYGGAATCCC-3Ј and 5Ј-CGTTGTG TTCAAGGCAAGT-3Ј.
Abs, immunofluorescence, and flow cytometry
Staining was performed on freshly isolated splenocytes as previously described (14) . The following Abs were used: RA3-6B2 anti-CD45R/B220, AMS 9.1 anti-IgD, R6-60.2 anti-IgM, B3B4 anti-CD23, 4E5 anti-Ly49D, 4D11 anti-Ly49G2, and 7G6 anti-CD21 M1/69 anti-CD24; all mAb were obtained from BD Pharmingen.
Stimulation of primary B cells
For Ly49D or Ly49G2 stimulation, 5 ϫ 10 6 primary B cells were suspended in 100 l of DMEM containing 10% (v/v) FCS. Then 5 g of 4E5 mAb or 4D11 mAb was added to each tube, and the tubes were immediately placed at 37°C for 2.5 min. Immediately after stimulation, the cells were washed and fast-frozen in liquid N 2 .
Preparation of cell extract
Stimulated cells were lysed in lysis buffer containing 25 mM Tris (pH 7.4), 2 mM vanadate, 75 mM glycophosphate (pH 7.2), 2 mM EDTA, 2 mM EGTA, 10 mM tetrasodium pyrophosphate, and 0.5% Nonidet P-40 in the presence of the following protease inhibitors: 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin, 10 mg/ml chymostatin (Roche), 1 mM PMSF (Sigma-Aldrich), and 20 mM N-ethylmalemide (Sigma-Aldrich).
Immunoprecipitation and Western blot analysis
Protein G-Sepharose beads (Pharmacia Biotech) were conjugated to phosphorylated tyrosine (p-Tyr) mAb (Santa Cruz Biotechnology) at a 1:20 ratio for 2 h at 4°C, followed by three washes in PBS. Beads were added to the cell lysates and p-Tyr proteins were immunoprecipitated overnight. The protein G-bound material was washed three times with PBS containing 0.1% SDS and 0.5% Nonidet P-40. Lysates or immunoprecipitates were separated by 10% (w/v) SDS-PAGE. The proteins were transferred into nitrocellulose membrane and probed with anti-p-Tyr99 (Santa Cruz Biotechnology), followed by HRP-conjugated anti-mouse or anti-rabbit IgG (Jackson ImmunoResearch Laboratories) or anti-Syk (Santa Cruz Biotechnology), followed by HRP-conjugated anti-rabbit IgG (Jackson ImmunoResearch Laboratories).
Syk inhibition
Immature B cells from Ii
Ϫ/Ϫ were incubated in the presence of 120 M of the Syk inhibitor, piceatannol (Sigma-Aldrich) or in the presence of DMSO. After 3 h of incubation at 37°C, the cells were immediately washed, and RNA was purified.
Detection of IFN-␥
Lysates of cells were separated by 10% (w/v) SDS-PAGE. IFN-␥ was detected as previously described (3).
Intracellular staining
Total splenocytes (10 6 cells/ml) were incubated in the presence of PMA (50 ng/ml) and ionomycin (750 ng/ml) for 2 h. Cells were then incubated for 4 h with brefeldin A (10 g/ml). The cells were blocked with anti-FcR and stained for cell surface B220, then fixed in PBS with 4% paraformaldehyde and permeabilized in PBS with 0.1% saponin, 5%FCS, and 0.1% azide. After permeabilization, cells were stained with FITC-conjugated antimouse IFN-␥ ((XMG1.2; BD Pharmingen) or an FITC-conjugated isotype control (BD Pharmingen). IFN-␥ expression was analyzed by FACS.
Cytoskeleton rearrangement
B cells were stimulated for 1 h in the presence or the absence of antiLy49D, Ly49G2, or both (BD Pharmingen) at 37°C as described above. Cytoskeleton rearrangement was evaluated as previously described (4) .
ELISA
Ii
Ϫ/Ϫ immature CD19 ϩ cells were stimulated in the presence or the absence of anti-Ly49G2 as described above. Cell supernatants were collected, and IFN-␥ levels were determined by ELISA (BD Pharmingen) according to the manufacturer's instructions.
Tracking of cells in vivo
Ii
Ϫ/Ϫ B cells were stimulated in the presence or the absence of antiLy49G2 or control Ab (anti-CD8). After 1 h, the cells were labeled with 5 M CFDA-SE (Molecular Probes) for 15 min at room temperature. The cells were then injected into control mice, and spleen and LN were analyzed 3 h later by FACS.
Calculation of ratio
The ratio in each figure was calculated as the intensity of a band divided by the intensity of hypoxanthine phosphoribosyltransferase, tubulin, or an unrelated band in untreated or lesser expressing cells, was normalized to 1. The ratio for the treatment was calculated as the intensity for that treatment relative to 1.
Results
B cells express active Ly49G2 receptor on their surface that is up-regulated throughout maturation
The Ly49D and Ly49G2 receptors are commonly expressed as pairs on NK cells (8) The newly arrived immature B cells enter the spleen through the central arteriole and develop into T1 cells, which are located at the outer periarteriolar lymphoid sheath. They then develop into T2 cells, which are situated within primary follicles and adjacent to mature cells (15) . To determine at which specific stage of differentiation Ly49G2 transcription is up-regulated, we sorted these populations using cell surface markers attributed to each population (13) and followed their Ly49D and Ly49G2 messages by RT-PCR. As shown in Fig. 1F , although Ly49D message was down-regulated during the differentiation from T1 to T2 B cells, Ly49G2 mRNA was increased during the transition to T2 cells. Thus, Ly49D and Ly49G2 RNA levels were inversely regulated over the course of B cell maturation. Cells that expressed high levels of Ly49D showed low levels of Ly49G2 and vice versa.
To directly show cell surface expression of Ly49G2 on mature B cells, B cells derived from control or Ii Ϫ/Ϫ mice were analyzed by FACS for Ly49G2 expression. As shown in Fig. 2A , Ii Ϫ/Ϫ immature B cells expressed lower levels of Ly49G2 than the control B populations (B220 ϩ , IgM ϩ , or CD19 ϩ ). However, Ly49G2 expression levels on mature B cells were still lower than the cell surface Ly49G2 levels on the B220-negative population or NK1.1 cells (Fig. 2B ). In addition, control immature B cells (IgD Ϫ or CD23 Ϫ B220 ϩ cells) expressed lower levels of Ly49G2 receptor, which was significantly elevated on the mature (IgD ϩ or CD23 ϩ ) population (Fig. 2C) . These results show that, unlike Ly49D, which is expressed on immature B cells and dramatically downregulated during differentiation to mature cells (6), Ly49G2 expression follows an inverse pattern and is expressed mostly on mature cells.
To determine whether incubation of immature and mature B cells with anti-Ly49G2 Ab induces a signaling cascade, Ii Ϫ/Ϫ B cells and control B cells were stimulated with anti-Ly49G2 (4D11) Abs. As shown in Fig. 3, A and B, anti-Ly49G2 induced a specific phosphorylation of several proteins, peaking 2.5 min after stimulation, showing that Ly49G2 expressed on these cells is active. Moreover, activation of Ly49G2 on Ii Ϫ/Ϫ B cells resulted in stimulation, but to a lesser extent (Fig. 3C) .
We have previously shown that immature BM B cells express low levels of Ly49D. After their exit from the BM compartment, Ly49D is up-regulated on the peripheral immature population (6) . To determine the expression of Ly49G2 in the immature BM cells, IgM ϩ IgD Ϫ BM B cells were separated, and their Ly49G2 mRNA levels were compared with those of peripheral immature (CD19 ϩ IgD Ϫ ) and mature (IgD ϩ ) populations. As shown in Fig. 4A , high levels of Ly49G2 message were detected in immature BM B cells. After their exit from the BM, these immature B cells down-regulated their Ly49G2 transcription. Differentiation to mature B cells resulted in elevation of Ly49G2 transcription to levels similar to those in BM cells. FACS analysis of Ly49G2 revealed that high protein levels of this receptor were expressed on immature BM cells (Fig. 4B) . Exit from the BM to the periphery was accompanied by downregulation of Ly49G2 cell surface expression on the peripheral immature population and its elevated expression on mature B cells (Fig. 4B) . Thus, BM and mature B cells exhibited similar Ly49 receptor expression patterns.
Activation of Ly49G2 on immature B cells leads to a decrease in IFN-␥ transcription and translation, and restores their cytoskeleton rearrangement and migration
To determine whether IFN-␥ expression correlates with the expression of the Ly49 family members, we analyzed IFN-␥ message in the various B cell populations. As shown in Fig. 4A , BM immature and mature B cells, which expressed high levels of Ly49G2, transcribed low levels of IFN-␥, whereas IFN-␥ transcription was increased in peripheral immature cells. In addition, during differentiation of immature T1 B cells to T2 and mature cells, there was a down-regulation in IFN-␥ expression levels (Fig.  1E) . Thus, IFN-␥ expression correlates with high levels of Ly49D and low Ly49G2 expression. We also wanted to determine whether Ly49G2 stimulation influences IFN-␥ expression in immature B cells. To this end, we followed IFN-␥ message in stimulated or unstimulated B cells derived from Ii Ϫ/Ϫ mice. Ii Ϫ/Ϫ CD19 ϩ cells were incubated in the presence or the absence of anti-Ly49G2, anti-Ly49D, or nonspecific Abs. The anti-Ly49 Abs were previously shown to each stimulate their corresponding receptor (Fig. 3, A and B) (6) . IFN-␥ mRNA was compared in unstimulated and stimulated cells by RT-PCR. As shown in Fig. 5 , A-C, Ly49D stimulation led to a substantial increase in the levels of IFN-␥ message, as we previously showed (6). However, Ly49G2 stimulation resulted in a substantial reduction in IFN-␥ mRNA levels (Fig. 5, A-C) below its levels in unstimulated cells or in cells stimulated with a nonspecific Ab (Fig. 5B) . Consistent with the dominant effect of the inhibitory Ly49G2 receptor, stimulation with both anti-Ly49D and antiLy49G2 resulted in the return of IFN-␥ message to levels similar to those in unstimulated cells (Fig. 5C) , further demonstrating the tight regulation of IFN-␥ transcription by both receptors.
Next, we stimulated immature B cells (Ii Ϫ/Ϫ ) with anti-Ly49G2 and followed IFN-␥ protein levels. Ly49G2 stimulation down-regulated IFN-␥ protein levels, as detected in immature B cells by Western blot analysis (Fig. 5D) or by ELISA of cell supernatants (Fig. 5E) . These results demonstrated down-regulation of both intracellular and secreted IFN-␥ after Ly49G2 stimulation. Thus, both Ly49G2 and Ly49D regulated IFN-␥ secretion in peripheral immature B cells. Although Ly49D stimulation resulted in augmented secretion of this cytokine (6), Ly49G2 activation inhibited IFN-␥ secretion.
Previously, we showed that specific low levels of IFN-␥ secreted by immature B cells inhibited adhesion and migration of immature and mature B cells, whereas at lower or higher levels of IFN-␥, this inhibition was released (3, 5) . To determine whether the decrease in IFN-␥ expression induced by Ly49G2 stimulation regulates the motility of the cells, and thus their migration, we followed the degree of actin polymerization in Ii Ϫ/Ϫ (immature) B cells in the presence or the absence of Ly49G2 stimulation. As shown in Fig. 6A , anti-Ly49G2 treatment caused a substantial increase in cytoskeleton rearrangement in response to CXCL12, a potent B cell chemoattractant (16) . This loss of inhibition could be explained by the decrease in IFN-␥ secretion to below its inhibitory levels. Our previous studies demonstrated that conditioned medium derived from immature B cells negatively regulates cytoskeleton rearrangement and migration of mature B cells (3, 4) . To show a down-regulation in IFN-␥ secretion in response to Ly49G2 stimulation, conditioned medium derived from unstimulated control or Ii Ϫ/Ϫ B cells and Ii Ϫ/Ϫ B cells stimulated in the presence of anti-Ly49G2 for 1 h was collected. Cytoskeleton rearrangement of mature B cells incubated in the various conditioned media was monitored. As shown in Fig. 6B , addition of conditioned media from immature cells exposed to Ly49G2 stimulation vs conditioned medium derived from unstimulated immature B cells resulted in a dramatic recovery (to wild-type levels) of the ability of mature B cells to polymerize their actin. This loss of inhibition could be explained by the reduction in IFN-␥ secretion to below its inhibitory levels. To show the tight control of IFN-␥ secretion, cytoskeleton rearrangement was monitored in immature B cells stimulated in the presence or the absence of anti-Ly49D, anti-Ly49G2, or both. As previously shown, Ly49D stimulation resulted in elevation of IFN-␥ secretion above its inhibitory levels (6). As shown above, Ly49G2 stimulation down-regulated IFN-␥ secretion to levels below its inhibitory dose. Combination of the two signals resulted in retrieval of the inhibitory effect to levels similar to those in untreated cells (Fig. 6C) . Thus, signals from the two opposite receptors resulted in the secretion of specific low levels of IFN-␥ that inhibited cytoskeleton rearrangement.
To demonstrate the biological effect of Ly49G2 stimulation, we next analyzed the entry of cells into LN in vivo after Ly49G2 activation. Total splenocytes from Ii Ϫ/Ϫ mice were stimulated in vitro in the presence of anti-Ly49G2 or a nonspecific (anti-CD8) Ab. The cells were washed and labeled with fluorescent dye, and an equal number of live cells was injected i.v. into C57BL/6 mice. The proportion of labeled cells recovered in the spleen and LN was determined 3 h after injection. The extent of labeled cell accumulation in the spleen was unaffected by the various pretreatments (Fig. 6D) . In contrast, migration of anti-Ly49G2-stimulated Ii Ϫ/Ϫ cells to the LN was significantly increased, whereas cells incubated with nonspecific Ab exhibited low migration (Fig. 6E) . Thus, Ly49G2 stimulation leads to a rapid decrease in IFN-␥ transcription and translation, enabling increased cytoskeletal rearrangement and homing of immature B cells to the LN.
MHC I D b recognition is required for Ly49G2 activation
We have previously shown that MHC I recognition is essential for the secretion of low dose IFN-␥ that results in down-regulation of immature B cell migration and homing (6) . was maintained, activation of Ly49D by Ab did not affect IFN-␥ levels (Fig. 7C) . These results suggest that recognition of H2-D b by Ly49G2 leads to down-regulation of IFN-␥ secretion. When this signal is absent, and the activating receptor is stimulated, even mature B cells can transcribe IFN-␥ message.
Finally, because Ly49G2 and Ly49D are activated by the same MHC class I ligand, we wanted to determine whether both receptors activate similar signaling cascades. To this end, we followed their downstream signaling pathways. Stimulation of NK Ly49D receptor led to recruitment of Syk and its phosphorylation (8) . We therefore analyzed Syk phosphorylation in Ii Ϫ/Ϫ cells after anti-Ly49D or anti-Ly49G2 stimulation. The phosphorylation of Syk was directly assessed by precipitation of phosphotyrosine proteins, followed by anti-Syk immunoblotting. As shown in Fig. 8 , although Ly49D stimulation led to a rapid phosphorylation of Syk (Fig. 8A) , activation of Ly49G2 did not result in elevated phosphorylation of this protein (Fig.  8B) . To determine whether Syk phosphorylation leads to IFN-␥ transcription, immature B cells were simulated with anti-Ly49D and incubated for 3 h in the presence or the absence of the Syk inhibitor, piceatannol (17) . As shown in Fig. 8C , piceatannol inhibited IFN-␥ transcription, suggesting that Syk activity is essential for IFN-␥ transcription, which inhibits B cell homing, whereas the inhibitory effects of Ly49G2 are not mediated through the Syk pathway.
Discussion
The Ly49 gene family encodes MHC class I-recognizing type II transmembrane receptors primarily on murine NK cells. Inhibitory Ly49 receptors allow murine NK cells to kill cells with aberrant class I MHC expression while sparing normal cells. This is accomplished by their recognition of specific class I MHC products and inhibition of NK cell lysis of cells that present a normal repertoire of class I MHC ligands. The inhibitory receptors contain cytoplasmic ITIMs that are phosphorylated upon stimulation, leading to recruitment of Src homology region 2-containing phosphatase 1 and attenuation of intercellular signaling that inhibits NK cell activity (18 -20) . Ly49 receptors that lack the cytoplasmic ITIM motif, which is required for inhibition of killing, and contain a positively charged residue in their transmembrane region (21) (22) (23) (24) stimulate NK killing and are therefore referred to as activating Ly49 receptors (25) .
One of the classic hallmarks of adaptive immunity is the strong synergy observed upon coreceptor activation. NK cells can express both activating and inhibitory Ly49 receptors on their cell surfaces. When cells expressing both receptors are presented with a ligand, inhibition dominates as the functional outcome (7, 26) . Ly49D receptor ligation can lead to the rapid and potent secretion of IFN-␥. Consistent with the dominant inhibitory function of Ly49G, NK cells coexpressing Ly49D and Ly49G show a profound reduction in IFN-␥ secretion after interaction with targets expressing their common ligand, H-2D d (26) . In this study we followed the expression of the inhibitory receptor, Ly49G2, on B cells and analyzed its interaction with the activating receptor, Ly49D, that was previously shown to be expressed on immature B cells (6) . We demonstrate for the first time that B cells display surface Ly49G2. Ly49G2 and Ly49D transcription, translation, and cell surface expression are coregulated during B cell differentiation. Although high levels of Ly49G2 are expressed in immature BM B cells, its expression is dramatically down-regulated in peripheral immature B cells. Differentiation to mature cells results in a strong enrichment of its expression levels. Furthermore, the Ly49G2 receptor on immature and mature B cells is functional and is able to tyrosine phosphorylate specific proteins after its stimulation. We have previously shown that Ly49D expression in B cells is regulated as well, but in an inverse pattern. Although bone marrow immature B cells express low levels of this receptor, peripheral immature cells dramatically up-regulate its levels, and differentiation to mature cells results in its reduced levels (6) . Thus, there is a tight regulation in the expression of the Ly49 family members on B cells.
Previously, we demonstrated that immature B cells can downregulate their own integrin-mediated adhesion to the extracellular matrix and thereby suppress their migration into nonsplenic sites. This inhibition is mediated by the chemokine receptor CCR2 (27) and IFN-␥, which is transcribed and secreted at low levels by immature B cells (3) . The inhibitory signal of IFN-␥ is transmitted through the IFN-␥R, whose engagement leads to inhibition of cytoskeleton rearrangement, which is required for promoting integrin-mediated adhesion and migration of B cells (4, 5) .
In this study we show that high Ly49G2 inhibits IFN-␥ expression in B cells. Although activation of Ly49D on immature B cells augments IFN-␥ transcription and secretion levels (6), cross-linking of Ly49G2 on these cells dramatically inhibits these processes and restores cytoskeleton rearrangement and homing of cells to LN. In addition, cross-linking of both Ly49D and Ly49G2 receptors on immature B cells results in transcription of specific low levels of IFN-␥. Thus, high levels of the inhibitory receptor expressed on immature BM and mature B cells dominate, and IFN-␥ secretion is largely inhibited; low levels of the inhibitory receptor, Ly49G2, coexpressed with high levels of the activating receptor, Ly49D, result in regulated and specific secretion of low levels of IFN-␥. This regulation insures the inhibitory control of immature B cells homing to the LN and removal of this regulation in BM and during the mature stage. b molecules, but that the affinity of this interaction may be too low to observe inhibition of target cell lysis in vitro, but sufficient to induce effects on Ly49A receptor expression in vivo (28 -30) . We believe that Ly49G2 in B cells might have a similar interaction with H2-D b , and this interaction should be further studied.
Our current model suggests that Ly49 family members regulate IFN-␥ by B cells from their formation stage in the BM through their maturation in the spleen. Immature BM B cells express high levels of Ly49G2 and low levels of Ly49D, resulting in inhibition of IFN-␥ secretion. In preparation for their exit to the periphery, these cells down-regulate their Ly49G2 expression and up-regulate cell surface Ly49D levels. MHC class I recognition leads to Ly49D activation, enabling the secretion of constant low levels of IFN-␥. We propose that this IFN-␥ breaks the CXCL12 retention signals in the BM, allowing the release of immature B cell from this compartment. IFN-␥ secretion by peripheral immature B cells prevents their arrival at Ag-enriched sites, allowing their direct targeting to the spleen. After their arrival at the spleen, immature B cells complete their maturation process. Mature B cells downregulate their Ly49D and elevate their Ly49G2 levels. Mature cells that no longer secrete IFN-␥ can recirculate in the periphery and home to various compartments, such as LN or sites of inflammation.
